Immediate Impact
48 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Hwankyu Kang being referenced
Abstract 2255: Patient pharmacodynamic biomarker and pk evaluation results from an ongoing phase I dose-escalation study of q702, an axl, mer and csf1r kinase inhibitor in patients with advanced solid tumors
2023
Abstract 4139: Q702, selective Axl, Mer and CSF1R triple kinase inhibitor with dual potentials leading to tumor regression: Immuno-oncology therapy and targeted cancer therapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hwankyu Kang | 16 | 92 | 99 | 73 | 9 | 199 | |
| Xin Wang | 8 | 111 | 113 | 48 | 13 | 214 | |
| Supreeth Guptha | 6 | 146 | 117 | 108 | 9 | 246 | |
| Naveen Kumar | 8 | 128 | 147 | 37 | 13 | 231 | |
| Hee Kyoung Jeon | 8 | 117 | 105 | 28 | 8 | 191 | |
| Selin Somersan-Karakaya | 8 | 86 | 152 | 94 | 13 | 260 | |
| Nathalie Lecat‐Guillet | 5 | 167 | 105 | 47 | 11 | 298 | |
| Vaishali Humnabadkar | 8 | 169 | 137 | 80 | 8 | 243 | |
| Claire J. Mackenzie | 5 | 163 | 94 | 80 | 9 | 241 | |
| Eva María López-Román | 37 | 123 | 142 | 93 | 9 | 251 | |
| Sudha Ravishankar | 9 | 184 | 88 | 49 | 13 | 284 |
All Works
Loading papers...